Albumin-to-Globulin Ratio at 1 Year after Anti-Tumor Necrosis Factor α Therapy Can Serve as a Prognostic Biomarker in Pediatric Crohn’s Disease Patients

BACKGROUND/AIMS: The efficacy of biologics for the treatment of Crohn’s disease (CD) is affected by the drug concentrations. We aimed to evaluate the importance of albumin and globulin which are known to be associated with drug concentrations as prognostic biomarkers in CD. METHODS: In total, 121 pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eun Sil, Kwon, Yiyoung, Choe, Yon Ho, Kim, Mi Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761917/
https://www.ncbi.nlm.nih.gov/pubmed/34092576
http://dx.doi.org/10.5009/gnl20322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761917/
https://www.ncbi.nlm.nih.gov/pubmed/34092576
http://dx.doi.org/10.5009/gnl20322

Ejemplares similares